Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin added to standard decolonization for MRSA throat carriage
2024-516377-69-01Phase 4Completed
- Sponsor
- Capital Region of Denmark
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in methicillin-resistant Staphylococcus aureus infection (MRSA) comparing Standard decolonization plus oral clindamycin with Standard decolonization plus placebo (2 arms). Started Oct 2024; status: completed.
02
Drugs
clindamycin
03
Conditions
methicillin-resistant Staphylococcus aureus infection (MRSA)
Beyond the preview
Go deeper on 2024-516377-69-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516377-69-01.